Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PIPPI

Financiado

Cerrado

Protein excipient Interactions and Protein Protein Interactions in formulation

The revolution of biotechnology has led to the creation of various types of therapeutic biologics with the potential to provide treatment for new chronic and malignant diseases. Though the potential advantages of biologics lay in... ver más

31/12/2019

TECHNICAL UNIVERSI...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-12-31

MSCA-ITN-2015-ETN: Marie Skłodowska-Curie Innovative T...

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

TECHNICAL UNIVERSITY OF DENM...

580.16K€ | Lider

NOVOZYMES AS

580.16K€ | Participante

NANOTEMPER TECHNOLOGIES GMBH

N.D. | Participante

WYATT

249.22K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ExtremoChem Chemically synthesised novel compounds for the stabilisation... 71K€ Cerrado

RTI2018-096344-B-I00 PLANTILLAS PEPTIDICAS RESTRINGIDAS PARA EL DISEÑO DE FARMACO... 57K€ Cerrado

BIO2013-49320-EXP REDISEÑO DE PROTEINAS TERAPEUTICAS MEDIANTE AMINOACIDOS NO P... 73K€ Cerrado

SHIFTIDES Shifting the oligomerization equilibrium of proteins a nove... 1M€ Cerrado

CTQ2015-68677-R ARQUITECTURAS PEPTIDICAS RESTRINGIDAS COMO PLANTILLAS PARA D... 67K€ Cerrado

PTQ-09-02-00017 Procedimiento de Formulación y Estabilización de Medicamento... 99K€ Cerrado

Duración del proyecto: 53 meses Fecha Inicio: 2015-07-31
Fecha Fin: 2019-12-31

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The revolution of biotechnology has led to the creation of various types of therapeutic biologics with the potential to provide treatment for new chronic and malignant diseases. Though the potential advantages of biologics lay in their high specificity and potency combined with few side effects, their formulation still remains a large challenge to pharmaceutical scientists. This is in part due to the complex, not-well understood relationship between the physicochemical properties of proteins and formulation conditions required for protein stability. A comprehensive understanding of the molecular mechanisms behind protein stabilization and solubility would provide the formulation scientists with knowledge of the interplay between formulation and stability that in turn could potentially make formulation development faster, cheaper and less labour intensive than the currently used broad screening approach. Understanding the susceptibilities of formulations to protein aggregation and denaturation can reduce the response time to for instance product failure. Few universities in Europe have formulation of biologics as a scientific subject. Consequently, the pharmaceutical industry is forced to train scientists - a challenge for larger companies, and an insurmountable task for smaller companies. Scientists in the field of structural biology, biophysics, protein formulation and stability have formed a consortium to systematically map physicochemical properties of biologics, formulation conditions and protein stability. The main objective of the consortium is to provide a new generation of innovative and entrepreneurial early-stage researchers that will develop methodologies, tools and databases to guide the formulation of robust biologics. The consortium will not only provide an excellent platform to train a new generation of formulation scientists, but also establish avenues for designing new formulation strategies and thereby securing the leading edge of EU expertise.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores